Jaehyun Choi
Chief Executive Officer Genexine
Seminars
Thursday 12th November 2026
Outlining BioPROTAC: A Novel TPD Payload In mRNA Therapy
2:30 pm
- Unveil an update of EPDegTM bioPROTAC development
- Discuss the proved differentiating points of bioPROTAC platform from others
- Learn the current challenges and future directions